?That Renault does not have a long-term connection is for us a little bit of an uncertainty.?. LONDON–(Business Wire)–RMAC 2003-NS4 PLC Report and Financial Statements Year ended 31 December 2008 Copies of the above document have been submitted to the UK Listing Authority andwill shortly be available for inspection at the UK Listing Authority`s DocumentViewing Facility, which is located at: UK Listing AuthorityThe Financial Services Authority25 The North ColonnadeCanary WharfLondonE14 5HS Tel : 020 7066 1000 RMAC 2003 NS4 PLC Copyright Business Wire 2009. . BILLERICA, Mass.–(Business Wire)–Bruker Corporation (NASDAQ: BRKR) today reported financial results for the firstquarter ended March 31, 2009. First Quarter 2009 Snapshot* GAAP Revenue decreased 3.3% * FX-Adjusted Revenue increased 4.5% * GAAP Net Income $8.4 million, EPS $0.05 per diluted shareFinancial ResultsIn the first quarter of 2009, revenue was $230.5 million, a decrease of 3.3%compared to revenue of $238.3 in the first quarter of 2008. Excluding theeffects of foreign currency translation, first quarter 2009 revenue increased by4.5% year-over-year. GAAP net income for the first quarter of 2009 was $8.4 million, or $0.05 perdiluted share, compared to a net loss of ($0.8) million, or ($0.00) per dilutedshare, in the first quarter of 2008.

Free cash flow for the first quarter of 2009 was $9.2 million, compared to $8.9million in the first quarter of 2008. During the first quarter of 2009, Brukerrepaid $20.2 million of debt and ended the quarter with cash and cashequivalents of $149.9 million, and net debt of $53.7 million. Comment and OutlookFrank Laukien, President and CEO, commented: “We are pleased with our firstquarter 2009 results, given the challenges in the marketplace today. During thefirst quarter, while we saw softness in our industrial and pharma/biotechorders, we recorded healthy orders from academic, medical school, government andother non-profit customers, which typically account for about two-thirds ofBruker`s revenue. While we continue to be below our gross margin and operatingmargin goals, we have started to see the effects of our cost-cutting initiativesand we expect to realize further savings in 2009. We continue to rationalize ourcost structure, but we also are investing in new opportunities, and haveintroduced a record number of important new products so far in 2009.” Dr. Laukien continued with an update on the outlook for 2009: “While certainindustrial and pharma market segments this year are even more challenging thanwe had expected, our non-profit, governmental and other healthcare orders remainstrong.

For example, we are excited about our double-digit order growth inlife-science mass spectrometry, driven by the compelling capabilities of ourhigh-performance products. We also see positive signs as a result of the variousinternational government stimulus packages, which in our opinion willparticularly benefit high-end research equipment. In Japan, we have already seenadditional orders and revenue, while elsewhere we have experienced a significantincrease in requests for proposals and assistance with grant writing. We arehopeful that global stimulus funding for academic, medical and governmentresearch will result in additional business for Bruker in the second half of2009 and into 2010.” Bruker`s CFO, Bill Knight, added: “The downturn in the global economy ischallenging to navigate and revenue was negatively affected by foreign currencyheadwinds in the first quarter. We continue to explore additional cost savingsopportunities, while improving our operational efficiency through productdesign, production process improvements and enhanced balance sheet management.” EARNINGS CONFERENCE CALLBruker Corporation will host an operator-assisted earnings conference call at10:00 a.m Eastern Daylight Time on Thursday, April 30, 2009.